☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
pembrolizumab
Samsung Bioepis Reports the Initiation of the P-I Trial Evaluation of SB27 (biosimilar, pembrolizumab) for the Treatment of Lung C...
March 4, 2024
Merck’s Keytruda (pembrolizumab) in Combination with Chemotherapy Receives CHMP’s Positive Opinion for the Treatment of Non-Small...
February 23, 2024
Merck Reports Results for Keytruda (pembrolizumab) in P-III Trial as an Adjuvant Therapy for Urothelial Carcinoma
January 29, 2024
Astellas Receives the EMA’s Validation on Type II Variation Application for Padcev (enfortumab vedotin) in Combination with Keytru...
January 29, 2024
Moderna and Merck Report Results from the P-IIb (KEYNOTE-942) Study of mRNA-4157 (V940) + Keytruda (pembrolizumab) for Resected Hi...
December 15, 2023
Merck’s Keytruda (pembrolizumab) Receives EC’s Approval as Adjuvant Treatment for Non-Small Cell Lung Cancer
October 17, 2023
Load more...
Back to Home